-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on vTv Therapeutics, Maintains $36 Price Target

Benzinga·08/13/2025 11:40:50
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar reiterates vTv Therapeutics (NASDAQ:VTVT) with a Buy and maintains $36 price target.